Algert Global LLC raised its holdings in Arhaus, Inc. (NASDAQ:ARHS – Free Report) by 21.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 103,261 shares of the company’s stock after purchasing an additional 18,040 shares during the quarter. Algert Global LLC owned 0.07% of Arhaus worth $1,271,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD purchased a new stake in shares of Arhaus during the 1st quarter worth about $8,326,000. Harbor Capital Advisors Inc. boosted its stake in shares of Arhaus by 273.4% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 153,764 shares of the company’s stock worth $2,605,000 after acquiring an additional 112,583 shares in the last quarter. Carnegie Investment Counsel boosted its stake in shares of Arhaus by 176.8% during the 3rd quarter. Carnegie Investment Counsel now owns 294,740 shares of the company’s stock worth $3,628,000 after acquiring an additional 188,240 shares in the last quarter. Sei Investments Co. boosted its stake in shares of Arhaus by 25.6% during the 2nd quarter. Sei Investments Co. now owns 481,331 shares of the company’s stock worth $8,154,000 after acquiring an additional 98,240 shares in the last quarter. Finally, Principal Financial Group Inc. purchased a new stake in shares of Arhaus during the 3rd quarter worth about $814,000. 27.88% of the stock is owned by hedge funds and other institutional investors.
Arhaus Stock Up 1.1 %
ARHS stock opened at $10.10 on Friday. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 18.04, a PEG ratio of 14.00 and a beta of 2.58. The company has a current ratio of 1.23, a quick ratio of 0.52 and a debt-to-equity ratio of 0.17. Arhaus, Inc. has a 12 month low of $8.30 and a 12 month high of $19.81. The firm has a 50-day moving average of $10.13 and a two-hundred day moving average of $13.41.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on ARHS. Telsey Advisory Group raised shares of Arhaus from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $11.00 to $12.00 in a research note on Thursday, November 14th. Barclays lowered their target price on shares of Arhaus from $15.00 to $13.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. Craig Hallum downgraded shares of Arhaus from a “buy” rating to a “hold” rating and reduced their price target for the stock from $14.00 to $10.00 in a research report on Tuesday, October 15th. TD Cowen reduced their price target on shares of Arhaus from $19.00 to $14.00 and set a “buy” rating for the company in a research report on Friday, August 9th. Finally, Stifel Nicolaus reduced their price target on shares of Arhaus from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $12.90.
Read Our Latest Stock Analysis on Arhaus
About Arhaus
Arhaus, Inc operates as a lifestyle brand and premium retailer in the home furnishings market in the United States. It provides merchandise assortments across various categories, including furniture, lighting, textiles, décor, and outdoor. The company's furniture products comprise bedroom, dining room, living room, and home office furnishings, which includes sofas, dining tables and chairs, accent chairs, console and coffee tables, beds, headboards, dressers, desks, bookcases, modular storage, and other items; and outdoor products, such as outdoor dining tables, chairs, chaises and other furniture, lighting, textiles, décor, umbrellas, and fire pits.
Read More
- Five stocks we like better than Arhaus
- How to Read Stock Charts for Beginners
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- ESG Stocks, What Investors Should Know
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Arhaus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arhaus and related companies with MarketBeat.com's FREE daily email newsletter.